223 related articles for article (PubMed ID: 36148971)
1. Mitochondria-Targeting Boron Dipyrromethene Based Photosensitizers for Enhanced Photodynamic Therapy: Synthesis, Optical Properties, and in vitro Biological Activity.
Hu P; Weng XL; Zhu CH; Yang DC; Liu JY; Chen Z; Huang M
Chempluschem; 2022 Sep; 87(9):e202200158. PubMed ID: 36148971
[TBL] [Abstract][Full Text] [Related]
2. Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene.
Sahoo S; Pathak S; Kumar A; Nandi D; Chakravarty AR
J Inorg Biochem; 2023 Jul; 244():112226. PubMed ID: 37105008
[TBL] [Abstract][Full Text] [Related]
3. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
4. Trifluoromethyl Boron Dipyrromethene Derivatives as Potential Photosensitizers for Photodynamic Therapy.
Liu JY; Zhou PZ; Ma JL; Jia X
Molecules; 2018 Feb; 23(2):. PubMed ID: 29463048
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic Reticulum-Localized Two-Photon-Absorbing Boron Dipyrromethenes as Advanced Photosensitizers for Photodynamic Therapy.
Zhou Y; Cheung YK; Ma C; Zhao S; Gao D; Lo PC; Fong WP; Wong KS; Ng DKP
J Med Chem; 2018 May; 61(9):3952-3961. PubMed ID: 29681157
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.
Lim SH; Thivierge C; Nowak-Sliwinska P; Han J; van den Bergh H; Wagnières G; Burgess K; Lee HB
J Med Chem; 2010 Apr; 53(7):2865-74. PubMed ID: 20199028
[TBL] [Abstract][Full Text] [Related]
7. Tetraphenylporphine-Modified Polymeric Nanoparticles Containing NIR Photosensitizer for Mitochondria-Targeting and Imaging-Guided Photodynamic Therapy.
Yuan P; Ruan Z; Yan L
ACS Biomater Sci Eng; 2020 Feb; 6(2):1043-1051. PubMed ID: 33464862
[TBL] [Abstract][Full Text] [Related]
8. A Platinum(II) Boron-dipyrromethene Complex for Cellular Imaging and Mitochondria-targeted Photodynamic Therapy in Red Light.
Upadhyay A; Nepalia A; Bera A; Saini DK; Chakravarty AR
Chem Asian J; 2023 Nov; 18(21):e202300667. PubMed ID: 37706570
[TBL] [Abstract][Full Text] [Related]
9. BODIPY and 2,3-Dihydrophthalazine-1,4-Dione Conjugates As Heavy Atom-Free Chemiluminogenic Photosensitizers.
Degirmenci A; Sonkaya Ö; Soylukan C; Karaduman T; Algi F
ACS Appl Bio Mater; 2021 Jun; 4(6):5090-5098. PubMed ID: 35007057
[TBL] [Abstract][Full Text] [Related]
10. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
[TBL] [Abstract][Full Text] [Related]
11. BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells.
Qi F; Yuan H; Chen Y; Guo Y; Zhang S; Liu Z; He W; Guo Z
J Inorg Biochem; 2021 May; 218():111394. PubMed ID: 33647541
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapy.
Zhang Y; Zhao R; Liu J; Kong H; Zhang K; Zhang YN; Kong X; Zhang Q; Zhao Y
Biomaterials; 2021 Aug; 275():120945. PubMed ID: 34126410
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of delocalized lipophilic cationic dyes as delivery vehicles for photosensitizers to mitochondria.
Ngen EJ; Rajaputra P; You Y
Bioorg Med Chem; 2009 Sep; 17(18):6631-40. PubMed ID: 19692249
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
15. A H₂O₂-Responsive Boron Dipyrromethene-Based Photosensitizer for Imaging-Guided Photodynamic Therapy.
Wang ZW; Su D; Li XQ; Cao JJ; Yang DC; Liu JY
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577688
[TBL] [Abstract][Full Text] [Related]
16. Molecular engineering to red-shift the absorption band of AIE photosensitizers and improve their ROS generation ability.
Zhang Y; Pan X; Shi H; Wang Y; Liu W; Cai L; Wang L; Wang H; Chen Z
J Mater Chem B; 2023 Apr; 11(14):3252-3261. PubMed ID: 36971133
[TBL] [Abstract][Full Text] [Related]
17. Oxoplatin-B, a cisplatin-based platinum(IV) complex with photoactive BODIPY for mitochondria specific "chemo-PDT" activity.
Bera A; Gautam S; Raza MK; Kondaiah P; Chakravarty AR
J Inorg Biochem; 2021 Oct; 223():111526. PubMed ID: 34246120
[TBL] [Abstract][Full Text] [Related]
18. Lysosome-targeted Aza-BODIPY photosensitizers for anti-cancer photodynamic therapy.
Hu M; Dong X; Zhao W
Bioorg Med Chem; 2024 Feb; 99():117583. PubMed ID: 38198943
[TBL] [Abstract][Full Text] [Related]
19. pH-Activatable Singlet Oxygen-Generating Boron-dipyrromethenes (BODIPYs) for Photodynamic Therapy and Bioimaging.
Radunz S; Wedepohl S; Röhr M; Calderón M; Tschiche HR; Resch-Genger U
J Med Chem; 2020 Feb; 63(4):1699-1708. PubMed ID: 31967820
[TBL] [Abstract][Full Text] [Related]
20. Heavy Atom-Free, Mitochondria-Targeted, and Activatable Photosensitizers for Photodynamic Therapy with Real-Time In-Situ Therapeutic Monitoring.
Miao J; Huo Y; Yao G; Feng Y; Weng J; Zhao W; Guo W
Angew Chem Int Ed Engl; 2022 Jun; 61(25):e202201815. PubMed ID: 35412694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
